secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2026-06-12T20:36:30+00:00
Accession:  0001193125-26-269567
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Climb Bio enters $100M ATM equity facility with Jefferies, terminates prior Oppenheimer agreement
--------------------------------------------------------------------------------

- Enters $100M at-the-market equity distribution agreement with Jefferies LLC for common stock sales.
- Jefferies will receive up to 3.0% of gross sales price per share; proceeds to fund general corporate purposes.
- Terminates prior $22.35M ATM facility with Oppenheimer & Co.; no shares were sold, no penalties incurred.
- Shares sold from time to time on Nasdaq Global Market at prevailing market prices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312526269567/0001193125-26-269567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312526269567/d92589d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-269567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer